Atzumi

News

More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi has been given the go-ahead by the agency.

News

The British Medical Association has branded a leaked proposal to rein back NHS recruitment and use more AI to compensate a "massive gamble."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.